查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1806622

急性復健市場按服務類型、疾病類型、階段類型、設備類型、患者年齡層、提供者類型和最終用戶分類 - 全球預測，2025 年至 2030 年

Acute Rehabilitation Market by Service Type, Disease Type, Phase Type, Device Type, Patient Age Group, Provider Type, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計急性康復市場在 2024 年的價值將達到 551 億美元，在 2025 年成長至 592.1 億美元，在 2030 年達到 858.2 億美元，複合年成長率為 7.66%。

主要市場統計數據
基準年2024年 551億美元
預計2025年 592.1億美元
預測年份 2030 858.2億美元
複合年成長率（%） 7.66%

隨著護理模式的演變和對綜合急性後解決方案的需求的成長，急性復健領域的創新已準備就緒

近年來，急性復健科已成為連結出院患者和長期功能恢復的關鍵環節。面臨心臟病、神經系統損傷、整形外科手術和慢性肺病的患者擴大尋求結構化復健項目，以恢復活動能力、認知功能和整體生活品質。這種日益成長的依賴源於人口結構變化（人口老化推動了對急性後期服務的需求）以及技術進步，這些技術進步使得能夠更準確地評估和監測患者病情進展。同時，醫療保健支付者和提供者也逐漸認知到早期療育策略在降低再入院率和總照護成本方面的價值。因此，急性復健計畫正在超越傳統的治療模式，融入數據主導、以患者為中心的方法。

探索透過科技整合、支付改革和以病人為中心的卓越照護重塑急性復原的變革

技術創新對於推動急性復健轉型至關重要。利用人工智慧和機器學習的平台正在透過預測患者病情進展並提前預警併發症來擴展臨床醫生的專業知識。穿戴式裝置和遠端監控工具正在將護理參與延伸到患者的家庭環境中，提高依從性並實現治療計劃的即時調整。隨著這些數位化模式的成熟，電子健康記錄和復健管理系統之間的互通性至關重要，這有利於無縫資料交換並促進更全面的護理協調。

評估2025年美國關稅對急性復健供應鏈、服務提供和成本結構的累積影響

2025年將實施的新關稅將影響一系列進口復健器械和設備，將對整個供應鏈和成本結構產生連鎖反應。製造商面臨機器人、輔助器具和物理治療設備關鍵零件進口關稅的提高。這些關稅的提高促使一些供應商加快在地化策略，尋求國內供應商或簽訂聯合生產協議，以緩解成本壓力並確保供應的連續性。

揭示了急性復健在服務類型、疾病類型、階段類型、設備類型、年齡層、提供者類型和最終用戶方面的深刻細分

依服務類型分析，我們發現急性復健生態系雖然支離破碎，但又相互依存。心臟復健計畫（包括心血管手術護理和心臟病發作後復健）與專注於活動能力訓練、平衡恢復和肌肉調理的門診物理治療服務緊密結合。神經復健工作（包括中風和腦外傷復健途徑）則利用職業治療技術和先進的機器人設備來增強神經可塑性。整形外科復健、肺部治療以及言語和語言介入進一步完善了這個體系，從而實現了無縫銜接的連續護理。

確定影響美洲、歐洲、中東和非洲以及亞太地區醫療保健領域急性復健的關鍵區域動態

在美洲，急性復健的特點是私人和公共醫療系統高度整合，主要醫療機構大力投資先進的機器人設備和遠端醫療平台。美國的衛生政策改革正在推動基於價值的支付方案的採用，獎勵早期復健活動和多學科護理團隊。在拉丁美洲，數位化應用速度較慢，但該地區正在擴大居家復健服務，以解決地理差異問題。

透過創新、策略夥伴關係和擴大服務組合，分析塑造急性復健未來的關鍵參與者

急性復健領域的主要企業正透過策略性研發投資和合作夥伴關係推動創新。領先的醫療設備製造商正專注於可適應多種治療方法的模組化機器人平台。同時，專注於遠端醫療的科技公司正與復健服務提供者合作，提供遠端監控和虛擬指導解決方案。

為行業領導者提供可行的建議，以利用急性復健趨勢並保持在急性後期護理中的競爭優勢。

醫療保健提供者應優先採用擴充性的數位平台，以實現遠距患者參與和即時數據分析，從而衡量功能改善。這種方法不僅可以增強護理協調，還能強化基於價值的護理提案，並使報銷獎勵與臨床結果保持一致。投資勞動力發展項目可以解決治療師短缺問題，並培養能夠有效運用新技術的多學科團隊。

為揭示見解、確保數據完整性和檢驗急性康復分析結果而採用的嚴格調查方法的詳細資訊

本分析以一個強大的研究框架為基礎，該框架融合了主要研究方法和次要研究方法。主要研究包括對高級管理人員、臨床主任和復健專業人員的深入訪談，以收集新興挑戰和創新驅動力的定性觀點。此外，我們還對付款方和醫療服務提供者進行了調查，以評估報銷趨勢和對技術採用的看法，從而補充了這些見解。

主要結論強調了急性復健領域相關人員的策略要務和未來方向

急性復健領域正處於曲折點。能夠有效整合數位健康解決方案和個人化多學科照護模式的機構，有望改善臨床療效並獲得有利的報銷安排。地理和人口細分為客​​製化服務組合提供了途徑，而區域差異則凸顯了根據當地監管和經濟狀況調整策略的重要性。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 增加住院復健設施（IRF）以促進專業康復
  • 根據即時患者數據制定​​個人化治療計劃的人工智慧演算法
  • 整合穿戴式感測器的遠端復健平台，最佳化患者活動能力
  • 機器人外骨骼促進中風後急性復健期間的活動能力改善
  • 擴大門診護理網路減少住院時間和費用
  • 穿戴式生物感測器的出現使得復健期間能夠持續監測生理恢復指標
  • 整合虛擬實境模組可增強患者在治療期間的參與度和依從性
  • 利用遠端醫療和遠端監控技術開發居家急性復健套件
  • 增加多學科中風復健項目，重點關注認知和功能結果測量
  • 由於老化，術後復健的需求增加

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章急性復健市場（依服務類型）

  • 心臟復健
    • 心血管手術後的治療
    • 心臟病發作後的康復
  • 神經復健
    • 中風復健
    • 創傷性腦損傷康復
  • 職能治療
  • 整形外科復健
  • 物理治療
    • 平衡與協調療法
    • 靈活性訓練
    • 肌力和耐力訓練
  • 肺康復
  • 語言和聽力治療

第9章急性復健市場（依疾病類型）

  • 心律不整
  • 心絞痛
  • 心房顫動
  • 膽固醇管理
  • 冠狀動脈繞道術
  • 冠狀動脈疾病或周邊動脈疾病
  • 糖尿病
  • 心臟衰竭或移植
  • 高血壓
  • 肺動脈高壓

第 10 章急性復健市場（依階段類型）

  • 第一階段（急性期）
  • 第二階段（亞急性期）
  • 第三階段（長期）
  • 第四階段（重新融入社會）

第 11 章急性復健市場（依設備類型）

  • 認知/音訊設備
  • 行動輔助設備
  • 監控工具
  • 物理治療設備
  • 機器人設備

第12章急性復健市場（依患者年齡層）

  • 成人
  • 老年人
  • 孩子們

第13章急性復健市場（依提供者類型）

  • 家庭康復
  • 醫院
  • 住院急性復健中心
  • 門診復健

第14章急性復健市場（依最終用戶）

  • 政府和公共衛生機構
  • 醫療保健提供者
  • 病人

第 15 章：美洲急性復健市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

16.歐洲、中東和非洲急性復健市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

17.亞太急性復健市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第18章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Acadia Healthcare Company, Inc.
    • Amedisys, Inc.
    • Athena Health Care Systems
    • Aurora Behavioral Health System
    • Cambridge Medical and Rehabilitation Center
    • CareOne Management, LLC by New Frontier Energy, Inc.
    • Covenant Care
    • Ekso Bionics Holdings, Inc.
    • Encompass Health Corporation
    • HCA Healthcare, Inc.
    • LHC Group, Inc. by UnitedHealth Group Incorporated
    • LifePoint Health, Inc.
    • National Healthcare Corporation
    • Nexion Health, Inc.
    • Oceans Healthcare
    • Promises Behavioral Health, LLC
    • St. Ann's Community
    • Tenet Healthcare Corporation
    • The Alden Network
    • The Ensign Group, Inc.
    • Universal Health Services Inc.
    • Genesis Healthcare, Inc.
    • Five Star Senior Living by AlerisLife Inc.
    • ClearSky Health
    • Paradigm Healthcare
    • Select Medical Corporation

第19章 研究人工智慧

第20章 研究統計

第21章 研究聯絡人

第22章 研究報導

第23章 附錄

Product Code: MRR-0376B2CAB000

The Acute Rehabilitation Market was valued at USD 55.10 billion in 2024 and is projected to grow to USD 59.21 billion in 2025, with a CAGR of 7.66%, reaching USD 85.82 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 55.10 billion
Estimated Year [2025] USD 59.21 billion
Forecast Year [2030] USD 85.82 billion
CAGR (%) 7.66%

Setting the Stage for Acute Rehabilitation Innovation Amid Evolving Care Paradigms and Growing Demand for Integrated Post-Acute Solutions

In recent years, the acute rehabilitation sector has emerged as a critical nexus between hospital discharge and long-term functional recovery. Patients facing cardiac events, neurological injuries, orthopedic procedures, or chronic pulmonary conditions increasingly rely on structured programs to restore mobility, cognitive function, and overall quality of life. This growing reliance has been fueled by demographic shifts, with an aging population driving demand for post-acute services, and technological advances that enable more precise assessment and monitoring of patient progress. In parallel, healthcare payers and providers have recognized the value of early intervention strategies to reduce readmission rates and lower total cost of care. Consequently, acute rehabilitation programs are evolving beyond traditional therapy models to embrace data-driven, patient-centered approaches.

More than ever, the acute rehabilitation landscape is being redefined by the convergence of clinical best practices and digital health innovations. Real-time telemonitoring, wearable sensors, and remote therapy platforms are extending the reach of interventions beyond hospital walls, facilitating continuity of care and enhancing patient engagement. This transformation is further supported by a shift in reimbursement policies that reward outcomes and value-based care, prompting providers to invest in integrated service lines and multidisciplinary teams. Such a holistic approach not only addresses physical impairments but also emphasizes psychosocial support, caregiver education, and home environment modifications to optimize recovery trajectories.

Despite these promising trends, the acute rehabilitation ecosystem faces significant challenges. Variability in care standards, limited access in rural or underserved areas, and resource constraints in post-acute facilities can impede timely initiation of therapy. Providers must also contend with workforce shortages, as the demand for specialized therapists outpaces available training programs. Payers are scrutinizing cost drivers and emphasizing care coordination, introducing performance benchmarks that necessitate robust data analytics capabilities. Simultaneously, patients and caregivers are demanding greater transparency, seamless communication, and personalized care plans that reflect individual goals and lifestyles.

In this executive summary, we embark on an in-depth exploration of the acute rehabilitation sector, examining transformative shifts, policy impacts, segmentation dynamics, regional nuances, and leading industry players. By synthesizing actionable insights and outlining methodological rigor, this report aims to equip stakeholders with a comprehensive understanding of the operating environment and strategic levers for value creation. The subsequent sections will illuminate critical trends, dissect tariff implications, and offer tailored recommendations to drive innovation, enhance patient outcomes, and foster sustainable growth in the evolving acute rehabilitation landscape.

Exploring Transformative Shifts Reshaping Acute Rehabilitation through Technological Integration, Payment Reforms and Patient-Centric Care Excellence

Technological innovation has been the lodestar guiding the transformation of acute rehabilitation. Platforms leveraging artificial intelligence and machine learning are now augmenting clinician expertise by delivering predictive insights into patient progress, flagging risks of complications before they emerge. Wearable devices and remote monitoring tools have extended therapeutic engagement into the patient's home environment, fostering adherence and enabling real-time adjustments to therapy plans. As these digital modalities mature, interoperability across electronic health records and rehabilitation management systems is becoming paramount, facilitating seamless data exchange and fostering more holistic care coordination.

Payment reforms and evolving reimbursement landscapes represent another pivotal shift. Traditional fee-for-service models are increasingly supplanted by value-based arrangements that reward measurable outcomes and penalize avoidable readmissions. This paradigm incentivizes providers to streamline care pathways, optimize resource allocation, and demonstrate efficacy through quantifiable metrics. Early adopters of bundled payment systems and accountable care contracts are already witnessing reductions in overall episode costs while preserving or enhancing patient functional gains.

Concurrently, there has been a decisive move toward patient-centric care excellence. The integration of behavioral health support, caregiver education, and community reintegration planning has broadened the scope of acute rehabilitation beyond pure physical therapy. Collaborative care models now incorporate social determinants of health assessments to tailor interventions that address factors such as housing stability, nutrition, and mental well-being. This holistic construct not only expedites recovery but also mitigates the risk of secondary complications.

Finally, strategic partnerships and consolidation trends are reshaping the competitive landscape. Healthcare systems, specialized rehabilitation providers, and technology vendors are forging alliances to deliver end-to-end solutions. These collaborations aim to combine clinical expertise with digital health platforms, creating ecosystems that support seamless transitions of care. As the sector continues to evolve, stakeholders who can align these multifaceted shifts into cohesive strategies will secure leadership positions in the acute rehabilitation market.

Assessing the Cumulative Impact of United States Tariffs in 2025 on Acute Rehabilitation Supply Chains, Service Delivery and Cost Structures

The introduction of new tariffs in 2025 affecting a range of imported rehabilitation equipment and devices has reverberated across supply chains and cost structures. Manufacturers have faced import duty increases on critical components used in robotics, mobility aids, and physiotherapy equipment. These levies have prompted some providers to accelerate localization strategies, seeking domestic suppliers or entering co-manufacturing agreements to mitigate cost pressures and ensure supply continuity.

Service delivery models have also adapted in response to tariff-driven cost escalations. Providers are exploring alternative sourcing channels and bulk procurement arrangements to spread financial burdens. In certain regions, acute rehabilitation operators have adjusted pricing models, rebalancing between bundled service fees and itemized billing for specialized equipment usage. These adjustments necessitate transparent communication with payers to sustain reimbursement rates aligned with rising input costs.

Moreover, the tariffs have influenced technology adoption timelines. Investments in advanced monitoring tools and robotic devices have been deferred or phased, as stakeholders reevaluate return-on-investment metrics under the new cost paradigm. Simultaneously, there has been renewed interest in lower-cost digital solutions, such as app-based rehabilitation programs and remote coaching platforms, offering more scalable deployment in a tariff-impacted market.

While these shifts have generated short-term financial strain, they have also catalyzed innovation. Collaboration between device manufacturers and rehabilitation providers has intensified to develop modular equipment that can be assembled or upgraded locally. This modularity reduces import dependencies and enhances customization to meet specific patient population needs. As the sector navigates these tariff influences, resilience and agility in supply chain management and strategic procurement practices will be pivotal to sustaining growth and preserving quality of care.

Revealing Insightful Segmentation of Acute Rehabilitation by Service, Disease, Treatment Phases, Device Types, Age Groups, Provider and End User Perspectives

Analysis by service type reveals a fragmented yet interdependent acute rehabilitation ecosystem. Cardiac rehabilitation programs, encompassing post-cardiac surgery therapy and post-heart attack recovery, are tightly integrated with outpatient physical therapy services that focus on mobility training, balance restoration, and strength conditioning. Neurological rehabilitation initiatives, comprising stroke and traumatic brain injury pathways, leverage both occupational therapy techniques and advanced robotic devices to enhance neural plasticity. Orthopedic rehabilitation, pulmonary therapy, and speech and language interventions further complement this matrix, enabling a seamless continuum of care.

When viewed through the lens of disease type, the acute rehabilitation market addresses conditions ranging from abnormal heart rhythms and atrial fibrillation to coronary artery bypass surgery aftercare. Management of high blood pressure and pulmonary hypertension often overlaps with diabetes education and heart failure transplant coordination, resulting in multidisciplinary programs that span clinical boundaries. By aligning therapeutic regimens with specific disease profiles, providers can deliver more personalized interventions that accelerate recovery while reducing resource duplication.

Phase-based segmentation underscores the evolving needs of patients. The acute or Phase I setting prioritizes stabilization and early mobilization immediately post-injury or surgery. Phase II transitions to sub-acute facilities or outpatient centers, focusing on progressive strength and endurance training. Phase III long-term care emphasizes community reintegration, while Phase IV targets full social and vocational return, often utilizing remote monitoring tools and telehealth touchpoints to sustain engagement.

Device type perspectives highlight the critical role of equipment in optimizing therapeutic outcomes. Cognitive and speech devices support neurological patients, whereas mobility devices and robotic platforms empower orthopedic and cardiac cohorts. Monitoring tools and physiotherapy equipment provide real-time feedback, enabling therapists to adjust interventions dynamically. This convergence of hardware underpins the precision of modern rehabilitation programs.

Patient demographics and provider formats further delineate service delivery. Adult, geriatric, and pediatric populations each present unique rehabilitation trajectories, prompting providers to tailor protocols accordingly. Settings range from home-based rehabilitation to hospitals, inpatient acute rehabilitation centers, and outpatient clinics, each offering distinct advantages in terms of intensity, accessibility, and cost structure. Finally, end users-spanning government and public health agencies, healthcare institutions, and directly engaged patients-interact with these segmented offerings to align clinical goals with budgetary and policy imperatives.

Illuminating Key Regional Dynamics Impacting Acute Rehabilitation across the Americas, Europe Middle East Africa and Asia Pacific Healthcare Landscapes

Across the Americas, acute rehabilitation is characterized by robust integration of private and public healthcare systems, where leading providers heavily invest in advanced robotic devices and telehealth platforms. Health policy reforms in the United States have driven adoption of value-based payment schemes, incentivizing early mobilization and multidisciplinary care teams. Latin America, while experiencing slower digital penetration, is progressively expanding home-based rehabilitation services to address geographic disparities.

In Europe, the Middle East and Africa region, established healthcare infrastructures in Western Europe showcase comprehensive post-acute networks supported by government reimbursement models. Central and Eastern European markets are witnessing gradual uptake of mobile monitoring tools as regulatory frameworks evolve. In the Middle East and Africa, public-private partnerships are emerging to fund rehabilitation centers that bridge urban-rural gaps, with an emphasis on tackling noncommunicable disease burdens.

The Asia-Pacific landscape is defined by rapid technological adoption and substantial investments in healthcare modernization. Countries like Japan and South Korea lead in integrating robotics and virtual reality therapies into acute settings, whereas India and Southeast Asia are scaling outpatient and home-based services to meet surging demand. Regulatory harmonization efforts and international collaborations are facilitating faster device approvals, fostering market expansion and cross-border knowledge exchange.

Profiling Leading Players Shaping the Future of Acute Rehabilitation through Innovation, Strategic Partnerships and Expanding Service Portfolios

Leading organizations in the acute rehabilitation space are driving innovation through strategic research and development investments and collaborative partnerships. Major medical device manufacturers are focusing on modular robotic platforms that can be adapted for diverse therapy modalities. Simultaneously, technology firms specializing in telehealth are aligning with rehabilitation providers to deliver remote monitoring and virtual coaching solutions.

Several global healthcare systems and specialty chains are optimizing their delivery networks by integrating inpatient, outpatient, and home-based rehabilitation under unified management structures. These vertically aligned models facilitate standardized protocols, centralized data analytics, and consistent quality measures. In parallel, smaller boutique providers are differentiating through niche offerings, such as pediatric neurological rehabilitation programs and geriatric balance training clinics that leverage culturally tailored interventions.

Strategic alliances between device innovators, software developers, and clinical centers of excellence are accelerating the translation of cutting-edge research into practical applications. Joint ventures are increasingly focused on spanning the full continuum of care, from acute phase stabilization to community reintegration, ensuring that patients benefit from seamless transitions and coherent treatment pathways. As competitive pressures intensify, organizations that can harness these collaborative networks to deliver integrated, outcome-driven solutions are poised to outperform in the acute rehabilitation market.

Delivering Actionable Recommendations for Industry Leaders to Capitalize on Acute Rehabilitation Trends and Sustain Competitive Advantage in Post-Acute Care

Providers should prioritize the adoption of scalable digital platforms that enable remote patient engagement and real-time data analytics to measure functional gains. This approach will not only enhance care coordination but also strengthen value-based care propositions, aligning clinical results with reimbursement incentives. Investing in workforce development programs will address therapist shortages and cultivate cross-disciplinary teams capable of deploying emerging technologies effectively.

Supply chain resilience can be fortified by establishing strategic partnerships with domestic component manufacturers and exploring modular equipment designs that reduce import dependencies. Such initiatives will mitigate the financial impacts of tariff fluctuations and ensure continuity of service delivery. Concurrently, negotiating volume-based procurement contracts with device vendors will leverage economies of scale and secure favorable pricing.

To capture regional growth opportunities, organizations should tailor service offerings to local regulatory environments and reimbursement structures. In emerging markets, expanding home-based rehabilitation networks through telehealth and mobile clinics can overcome geographic barriers. In developed markets, deepening integration across acute, sub-acute, and long-term care phases will drive differentiation and foster patient loyalty.

Finally, leaders must cultivate a culture of continuous innovation by fostering collaborations with academic institutions, technology incubators, and policy think tanks. By aligning strategic roadmaps with the latest clinical research and regulatory developments, organizations will be well-positioned to set industry benchmarks, drive superior patient outcomes, and achieve sustainable growth in the competitive acute rehabilitation arena.

Detailing Rigorous Research Methodology Employed to Uncover Insights, Ensure Data Integrity and Validate Findings in Acute Rehabilitation Analysis

This analysis was underpinned by a robust research framework combining primary and secondary methodologies. Primary research involved in-depth interviews with senior executives, clinical directors, and rehabilitation specialists to gather qualitative perspectives on emerging challenges and innovation drivers. These insights were complemented by surveys of payers and provider organizations to gauge sentiment on reimbursement trends and technology adoption.

Secondary research entailed a comprehensive review of peer-reviewed journals, government health policy publications, and industry white papers to validate market dynamics and regulatory shifts. Data triangulation techniques were employed to reconcile disparate data points and ensure consistency across sources. Market mapping and competitive benchmarking exercises were conducted to position key players according to service offerings, geographic presence, and innovation portfolios.

All findings underwent validation through a rigorous review process, engaging subject matter experts in rehabilitation medicine, healthcare economics, and supply chain management. This iterative vetting ensured that conclusions reflect the latest industry standards, best practices, and anticipated policy developments. By integrating qualitative insights with quantitative analysis, the methodology provides a holistic view of the acute rehabilitation sector's trajectory and strategic imperatives.

Synthesizing Critical Conclusions That Highlight the Strategic Imperatives and Future Directions for Stakeholders in the Acute Rehabilitation Sector

The acute rehabilitation sector is at an inflection point, defined by converging technological advances, policy reforms, and shifting patient expectations. Organizations that can effectively integrate digital health solutions with personalized, multidisciplinary care models will elevate clinical outcomes and secure favorable reimbursement arrangements. Geographic and demographic segmentation offers pathways to tailor service portfolios, while regional nuances underscore the importance of adaptive strategies that align with local regulatory and economic contexts.

Navigating tariff impacts requires proactive supply chain strategies and a willingness to explore modular equipment designs and domestic partnerships. Market leaders will be those who anticipate these external pressures and respond with agile procurement and cost management initiatives. Collaboration across the value chain-from device innovators to clinical providers and payers-will catalyze the development of comprehensive rehabilitation ecosystems that support patients from acute stabilization through full community reintegration.

Ultimately, the imperatives for stakeholders center on innovation, resilience, and patient-centered excellence. By embracing data-driven decision-making, fostering strategic alliances, and continuously optimizing care pathways, organizations can seize opportunities for growth and differentiation. This summary provides the foundational insights necessary to chart a forward-looking strategy in the evolving acute rehabilitation landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growth of inpatient rehabilitation facilities (IRFs) for specialized recovery
  • 5.2. Artificial intelligence algorithms personalizing therapy regimens based on real-time patient data
  • 5.3. Tele-rehabilitation platforms integrating wearable sensors to optimize patient mobility
  • 5.4. Robotic exoskeleton adoption accelerating mobility outcomes in post-stroke acute rehab settings
  • 5.5. Expansion of outpatient acute rehabilitation networks reducing hospital length of stay and costs
  • 5.6. Emergence of wearable biosensors enabling continuous monitoring of physiological recovery markers in rehab
  • 5.7. Integration of virtual reality modules enhancing patient engagement and adherence in therapy sessions
  • 5.8. Development of home-based acute rehabilitation kits leveraging telehealth and remote monitoring technologies
  • 5.9. Growth of multidisciplinary stroke recovery programs emphasizing cognitive and functional outcome measures
  • 5.10. Rise in post-surgical rehabilitation demand driven by aging population

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Acute Rehabilitation Market, by Service Type

  • 8.1. Introduction
  • 8.2. Cardiac Rehabilitation
    • 8.2.1. Post Cardiac Surgery Therapy
    • 8.2.2. Post Heart Attack Rehabilitation
  • 8.3. Neurological Rehabilitation
    • 8.3.1. Stroke Rehabilitation
    • 8.3.2. Traumatic Brain Injury Rehabilitation
  • 8.4. Occupational Therapy
  • 8.5. Orthopedic Rehabilitation
  • 8.6. Physical Therapy
    • 8.6.1. Balance and Coordination Therapy
    • 8.6.2. Mobility Training
    • 8.6.3. Strength and Endurance Training
  • 8.7. Pulmonary Rehabilitation
  • 8.8. Speech & Language Therapy

9. Acute Rehabilitation Market, by Disease Type

  • 9.1. Introduction
  • 9.2. Abnormal Heart Rhythms
  • 9.3. Angina
  • 9.4. Atrial Fibrillation
  • 9.5. Cholesterol Management
  • 9.6. Coronary Artery Bypass Surgery
  • 9.7. Coronary or Peripheral Artery Disease
  • 9.8. Diabetes
  • 9.9. Heart Failure or Transplant
  • 9.10. High Blood Pressure
  • 9.11. Pulmonary Hypertension

10. Acute Rehabilitation Market, by Phase Type

  • 10.1. Introduction
  • 10.2. Phase I (Acute)
  • 10.3. Phase II (Sub-acute)
  • 10.4. Phase III (Long-term)
  • 10.5. Phase IV (Reintegration)

11. Acute Rehabilitation Market, by Device Type

  • 11.1. Introduction
  • 11.2. Cognitive/Speech Devices
  • 11.3. Mobility Devices
  • 11.4. Monitoring Tools
  • 11.5. Physio Equipment
  • 11.6. Robotic Devices

12. Acute Rehabilitation Market, by Patient Age Group

  • 12.1. Introduction
  • 12.2. Adults
  • 12.3. Geriatrics
  • 12.4. Pediatrics

13. Acute Rehabilitation Market, by Provider Type

  • 13.1. Introduction
  • 13.2. Home Based Rehabilitation
  • 13.3. Hospitals
  • 13.4. Inpatient Acute Rehabilitation Centers
  • 13.5. Outpatient Rehabilitation

14. Acute Rehabilitation Market, by End User

  • 14.1. Introduction
  • 14.2. Government & Public Health Agencies
  • 14.3. Healthcare Providers
  • 14.4. Patients

15. Americas Acute Rehabilitation Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa Acute Rehabilitation Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific Acute Rehabilitation Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Acadia Healthcare Company, Inc.
    • 18.3.2. Amedisys, Inc.
    • 18.3.3. Athena Health Care Systems
    • 18.3.4. Aurora Behavioral Health System
    • 18.3.5. Cambridge Medical and Rehabilitation Center
    • 18.3.6. CareOne Management, LLC by New Frontier Energy, Inc.
    • 18.3.7. Covenant Care
    • 18.3.8. Ekso Bionics Holdings, Inc.
    • 18.3.9. Encompass Health Corporation
    • 18.3.10. HCA Healthcare, Inc.
    • 18.3.11. LHC Group, Inc. by UnitedHealth Group Incorporated
    • 18.3.12. LifePoint Health, Inc.
    • 18.3.13. National Healthcare Corporation
    • 18.3.14. Nexion Health, Inc.
    • 18.3.15. Oceans Healthcare
    • 18.3.16. Promises Behavioral Health, LLC
    • 18.3.17. St. Ann's Community
    • 18.3.18. Tenet Healthcare Corporation
    • 18.3.19. The Alden Network
    • 18.3.20. The Ensign Group, Inc.
    • 18.3.21. Universal Health Services Inc.
    • 18.3.22. Genesis Healthcare, Inc.
    • 18.3.23. Five Star Senior Living by AlerisLife Inc.
    • 18.3.24. ClearSky Health
    • 18.3.25. Paradigm Healthcare
    • 18.3.26. Select Medical Corporation

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. ACUTE REHABILITATION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. ACUTE REHABILITATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ACUTE REHABILITATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. ACUTE REHABILITATION MARKET: RESEARCHAI
  • FIGURE 30. ACUTE REHABILITATION MARKET: RESEARCHSTATISTICS
  • FIGURE 31. ACUTE REHABILITATION MARKET: RESEARCHCONTACTS
  • FIGURE 32. ACUTE REHABILITATION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. ACUTE REHABILITATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST CARDIAC SURGERY THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST CARDIAC SURGERY THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST HEART ATTACK REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST HEART ATTACK REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TRAUMATIC BRAIN INJURY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TRAUMATIC BRAIN INJURY REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ORTHOPEDIC REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ORTHOPEDIC REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BALANCE AND COORDINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BALANCE AND COORDINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY TRAINING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STRENGTH AND ENDURANCE TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STRENGTH AND ENDURANCE TRAINING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPEECH & LANGUAGE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPEECH & LANGUAGE THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I (ACUTE), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I (ACUTE), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II (SUB-ACUTE), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II (SUB-ACUTE), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III (LONG-TERM), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III (LONG-TERM), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV (REINTEGRATION), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV (REINTEGRATION), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COGNITIVE/SPEECH DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COGNITIVE/SPEECH DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MONITORING TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MONITORING TOOLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSIO EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSIO EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROBOTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROBOTIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GERIATRICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME BASED REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME BASED REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY INPATIENT ACUTE REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY INPATIENT ACUTE REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 169. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 171. CANADA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. CANADA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. CANADA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. CANADA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 175. CANADA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. CANADA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. CANADA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. CANADA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 187. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 189. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 195. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. MEXICO ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 205. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 207. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 215. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 223. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 224. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 225. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 226. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 227. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 231. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 235. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 265. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. GERMANY ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 285. GERMANY ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 287. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 289. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 293. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 297. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. GERMANY ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. GERMANY ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 301. FRANCE ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. FRANCE ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 303. FRANCE ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 304. FRANCE ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 305. FRANCE ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 306. FRANCE ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 307. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 308. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 309. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 311. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 315. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 316. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 317. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. FRANCE ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. FRANCE ACUTE REHABILITATION MARKET SIZE, BY END USE